Diarrhea Completed Phase 3 Trials for Rifaximin (DB01220)

Also known as: Diarrhoea / Diarrhea NOS / Diarrhoea NOS

IndicationStatusPhase
DBCOND0021431 (Diarrhea)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00979056Prophylactic Treatment of Travellers' Diarrhoea With RifaximinPrevention
NCT00742469Rifaximin for Prevention of Travellers' DiarrheaPrevention
NCT02498418Study Comparing Rifaximin With Xifaxan 200 mg in Traveler's DiarrheaTreatment
NCT00328380Prevention of Travelers' Diarrhea in Subjects Traveling Outside the U.S.Prevention
NCT00269399A Trial to Compare Xifaxan to Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD)Treatment